Status:
UNKNOWN
Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome
Lead Sponsor:
Shaheed Zulfiqar Ali Bhutto Medical University
Conditions:
Steroid-Sensitive Nephrotic Syndrome
Eligibility:
All Genders
1-8 years
Phase:
NA
Brief Summary
All children from 1 to 8 years of age, diagnose with nephrotic syndrome for the first time will be divided into two groups. One group will be given steroids for 12 weeks and other group will receive s...
Detailed Description
All children from 1 to 8 years of age, diagnose with nephrotic syndrome for the first time, at Pakistan Institute of Medical Sciences, Islamabad, from December 2020 to December 2022 will be included i...
Eligibility Criteria
Inclusion
- Children 1 to 8 years of age,
- Diagnose with nephrotic syndrome for the first time
- Steroid sensitive nephrotic syndrome
Exclusion
- Steroid resistant nephrotic syndrome
- Steroid dependent nephrotic syndrome
- Syndromic Children
- Children with other co morbidities
Key Trial Info
Start Date :
December 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 4 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04713410
Start Date
December 22 2020
End Date
September 4 2023
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan Institute of Medical Sciences
Islamabad, Capital, Pakistan, 44000